Patent ID: 11950936
Assignee: ABBOTT DIABETES CARE INC.
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A  G

Claim 0:
1. An on body unit configured to provide notification of an adverse condition, the on body unit comprising:
an in vivo analyte sensor at least a portion of which is configured to be in contact with a bodily fluid;
sensor electronics coupled with the in vivo analyte sensor, the sensor electronics comprising:
a wireless communication module;
one or more processors coupled with a memory, the memory storing instructions that, when executed by the one or more processors, cause the one or more processors to:
receive and store time spaced analyte related signals from the in vivo analyte sensor;
process the received time spaced analyte related signals and monitor for the adverse condition;
transmit, by the wireless communication module, one or more of the received time spaced analyte related signals to a reader device according to a first power level of a power source coupled with the wireless communication module;
in response to a detected adverse condition, generate a notification signal, increase the first power level of the power source to a second power level of the power source, and transmit, by the wireless communication module, the generated notification signal to the reader device according to the second power level.